Skip to main content
. 2020 Jun 5;8:476. doi: 10.3389/fbioe.2020.00476

Figure 3.

Figure 3

Relative protein expression of non-phosphorylated (active) β-catenin in OU at Day 3 of rhRSPO1 (500 ng/mL) or PBS treatment, as assessed by Western blot in three independent experiments. (A) Western blot analysis of non-phosphorylated (active) β-catenin: Ladder; Exp1 Control; Exp1 rhRSPO1; Exp2 Control; Exp2 rhRSPO1; Exp3 Control; Exp3 rhRSPO1. (B) WB densitometric analysis (quantification). Student t-test was carried out for statistical analysis. *p < 0.05.